Bridges Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$965K Sell
5,548
-3,455
-38% -$611K 0.53% 57
2017
Q3
$1.68M Sell
9,003
-16,866
-65% -$2.99M 0.93% 31
2017
Q2
$4.46M Buy
25,869
+11,688
+82% +$1.9M 1.01% 38
2017
Q1
$2.33M Sell
14,181
-11,428
-45% -$1.9M 0.68% 36
2016
Q4
$3.74M Buy
25,609
+786
+3% +$118K 0.91% 38
2016
Q3
$4.14M Buy
24,823
+615
+3% +$104K 0.87% 37
2016
Q2
$3.68M Buy
24,208
+1,070
+5% +$166K 0.81% 36
2016
Q1
$3.47M Buy
23,138
+562
+2% +$83.5K 0.75% 43
2015
Q4
$3.47M Hold
22,576
0.6% 44
2015
Q3
$3.47M Buy
22,576
+4,923
+28% +$776K 0.6% 44
2015
Q2
$2.71M Buy
17,653
+5,520
+45% +$884K 0.64% 48
2015
Q1
$1.94M Buy
12,133
+384
+3% +$60.5K 0.44% 66
2014
Q4
$1.87M Sell
11,749
-820
-7% -$128K 0.43% 65
2014
Q3
$1.76M Buy
12,569
+30
+0.2% +$3.92K 0.41% 68
2014
Q2
$1.48M Buy
12,539
+1,738
+16% +$201K 0.34% 76
2014
Q1
$1.33M Sell
10,801
-300
-3% -$36.4K 0.31% 78
2013
Q4
$1.27M Buy
11,101
+1,442
+15% +$164K 0.29% 84
2013
Q3
$1.08M Buy
9,659
+859
+10% +$93.1K 0.27% 90
2013
Q2
$868K Buy
+8,800
New +$913K 0.22% 96

Other funds holding AMGN

Bridges Investment Counsel's AMGN Position: Q4 2017 in Review

Bridges Investment Counsel reduced its Amgen (AMGN) stake by 38% in Q4 2017, selling an estimated $611K and leaving 5,548 shares worth $965K. The position accounts for 0.53% of the portfolio, ranked #57.

Bridges Investment Counsel first reported a position in AMGN in Q2 2013 and has held it in 19 quarters since. The position peaked at $4.46M in Q2 2017. 1,734 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

  • Bridges Investment Counsel held 5,548 shares of Amgen worth $965K as of Q4 2017.
  • Bridges Investment Counsel sold 3,455 Amgen shares in Q4 2017, an estimated $611K.
  • Amgen made up 0.53% of Bridges Investment Counsel's portfolio in Q4 2017, its #57 holding.
  • Bridges Investment Counsel first reported a position in Amgen in Q2 2013 and has held it in 19 quarters since.
  • Bridges Investment Counsel's Amgen position peaked at $4.46M in Q2 2017.
  • 1,734 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.